SOPHARMA AD (108/2017) CONSILIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 SEPTEMBER 2017
Report no 108/2017
- 29.11.2017, 14:17
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (107/2017) Award from the Vienna Economic Forum "Vienna future dialogue 2017"
Report no 107/2017- 16.11.2017, 14:20
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (106/2017) The company BRIZ, a subsidiary of Sopharma, was awarded with the Paracelsus award.
Report no 106/2017- 16.11.2017, 14:15
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (105/2017) Meeting with investors of Sopharma AD
Report no 105/2017- 06.11.2017, 11:47
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (104/2017) Sales revenues for the first ten months of 2017
Report no 104/2017- 03.11.2017, 13:01
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (103/2017) INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 September 2017
Report no 103/2017- 30.10.2017, 14:37
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (102/2017) Annual Meeting with Investors
Report no 102/2017- 05.10.2017, 15:01
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (101/2017) Sales revenues for the first nine months of 2017
Report no 101/2017- 04.10.2017, 16:28
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (100/2017) Current report 100 re insiders transactions -Doneva
Report no 100/2017- 02.10.2017, 13:23
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (99/2017) Acquisition of own shares from 26 September 2017
Report no 99/2017- 29.09.2017, 15:08
- Kategoria: Biznes i finanse
- Źródło: ESPI
